This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Institut Pasteur. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Alexandra Fizet
Introduction
Alexandra Fizet is a prominent inventor based in Les Echets, France. She has made significant contributions to the field of immunology, particularly through her work on recombinant viruses. With a total of 2 patents, her research focuses on developing innovative solutions to induce immune responses in subjects.
Latest Patents
Fizet's latest patents include an immunogenic composition comprising a recombinant attenuated Mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity. This invention involves a recombinant attenuated Mopeia virus (MOPV) that encodes a nucleoprotein with attenuated exonuclease activity and optionally encodes a non-MOPV arenavirus glycoprotein. The use of this recombinant attenuated MOPV aims to induce an immune response in a subject. Another patent details a similar recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity, further emphasizing her focus on enhancing immune responses.
Career Highlights
Alexandra Fizet is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to the field of microbiology and immunology. Her work at this prestigious institute has allowed her to explore innovative approaches to vaccine development and immune response mechanisms.
Collaborations
Fizet collaborates with notable colleagues such as Sylvain Baize and Audrey Page. These partnerships enhance her research capabilities and contribute to the advancement of her projects.
Conclusion
Alexandra Fizet's innovative work in the field of immunology, particularly through her patents on recombinant viruses, showcases her dedication to advancing medical science. Her contributions are significant in the ongoing efforts to develop effective immunogenic compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
